BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 25605450)

  • 1. Roadblocks preventing personalized medicine from reaching its potential.
    Cohen JP
    Biomark Med; 2015; 9(1):5-8. PubMed ID: 25605450
    [No Abstract]   [Full Text] [Related]  

  • 2. Ancestry, ancestry-informative markers, asthma, and the quest for personalized medicine.
    Barnes KC
    J Allergy Clin Immunol; 2010 Dec; 126(6):1139-40. PubMed ID: 21134571
    [No Abstract]   [Full Text] [Related]  

  • 3. Biomarkers in drug development and regulation: a paradigm for clinical implementation of personalized medicine.
    Zineh I; Huang SM
    Biomark Med; 2011 Dec; 5(6):705-13. PubMed ID: 22103607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of biomarkers on clinical trial risk.
    Reid GG; Bin Yameen TA; Parker JL
    Pharmacogenomics; 2013 Oct; 14(13):1645-58. PubMed ID: 24088135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers and personalized therapy in chronic kidney diseases.
    Schena FP
    Expert Opin Investig Drugs; 2014 Aug; 23(8):1051-4. PubMed ID: 24857812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Company Profile: AKESOgen, Inc.
    Bouzyk M; Boisjoli R
    Pharmacogenomics; 2012 Jul; 13(10):1115-8. PubMed ID: 22909201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The personalized medicine revolution: getting it right for children.
    Burckart GJ; Green DJ
    Pediatr Transplant; 2012 Sep; 16(6):530-2. PubMed ID: 22225514
    [No Abstract]   [Full Text] [Related]  

  • 8. Lexical fields of predictive and personalized medicine.
    Mathieu T; Bermont L; Boyer JC; Versuyft C; Evrard A; Cuvelier I; Couderc R; Peoc'h K;
    Drug Metabol Drug Interact; 2013; 28(2):125-32. PubMed ID: 23740683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pleomorphism of systemic sclerosis: are we ready for 'personalized medicine' in scleroderma?
    Steen VD
    Expert Rev Clin Immunol; 2011 Jul; 7(4):403-5. PubMed ID: 21790281
    [No Abstract]   [Full Text] [Related]  

  • 10. Meeting the technical challenges of personalized medicine and companion diagnostics.
    Montagna RA
    MLO Med Lab Obs; 2012 Jan; 44(1):16, 18, 20 passim. PubMed ID: 22352180
    [No Abstract]   [Full Text] [Related]  

  • 11. (13)C breath tests in personalized medicine: fiction or reality?
    Modak AS
    Expert Rev Mol Diagn; 2009 Nov; 9(8):805-15. PubMed ID: 19895226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalized medicine: will dentistry ride the wave or watch from the beach?
    Kornman KS; Duff GW
    J Dent Res; 2012 Jul; 91(7 Suppl):8S-11S. PubMed ID: 22699674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers for diabetes prediction, diagnosis and personalized therapy.
    Chen HB; Jia WP
    Chin Med J (Engl); 2012 Dec; 125(23):4163-6. PubMed ID: 23217380
    [No Abstract]   [Full Text] [Related]  

  • 14. [Lexical fields of predictive and personalized medicine].
    Mathieu T; Bermont L; Boyer JC; Versuyft C; Evrard A; Cuvelier I; Couderc R; Peoc'h K
    Ann Biol Clin (Paris); 2012; 70(6):651-8. PubMed ID: 23207809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacogenomics: current applications and future prospects towards personalized therapeutics.
    Vaiopoulou A; Gazouli M; Karikas GA
    J BUON; 2013; 18(3):570-8. PubMed ID: 24065466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalized medicine: progress and promise.
    Chan IS; Ginsburg GS
    Annu Rev Genomics Hum Genet; 2011; 12():217-44. PubMed ID: 21721939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personalized medicine policy challenges: measuring clinical utility at point of care.
    van Rooij T; Wilson DM; Marsh S
    Expert Rev Pharmacoecon Outcomes Res; 2012 Jun; 12(3):289-95. PubMed ID: 22812553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What is the future for cancer clinical trials?
    Perrone F
    Future Oncol; 2015; 11(1):5-7. PubMed ID: 25572779
    [No Abstract]   [Full Text] [Related]  

  • 19. Personalized medicine in oncology: where have we come from and where are we going?
    André F; Ciccolini J; Spano JP; Penault-Llorca F; Mounier N; Freyer G; Blay JY; Milano G
    Pharmacogenomics; 2013 Jun; 14(8):931-9. PubMed ID: 23746187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenomic biomarkers for personalized medicine.
    Chen JJ; Lin WJ; Chen HC
    Pharmacogenomics; 2013 Jun; 14(8):969-80. PubMed ID: 23746190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.